Business is business. Maybe it's about making a difference in the world of consumers but mostly, it's about making money. I get that -- and if I owned my own company and offered some sort of product, surely my goal would be to reap a financial reward. And if I wanted to increase my reward, I guess I would consider new markets, new advertising, and new techniques for hauling in loads of cash.

So I see what's going on with the new Camel No. 9 cigarettes, in their hot-pink fuscia and minty-teal green packages with the slogan Light and Luscious. I understand this brand is targeting female smokers with enticing wording that Camel maker R.J. Reynolds executives say is meant to suggest dressed to the nines, putting on your best. I even get that it's a pretty savvy strategy. But somehow, it all seems so wrong.

In a world where more women die of lung cancer than breast cancer -- by a large margin -- how can anyone, even business people whose sights are set on profits, feel OK with the decision to encourage women to smoke?

Think about these passages that just recently published in a New York Times article:

Wall Street analysts praise the introduction of Camel No. 9, in regular and menthol flavors, as a further step by the R. J. Reynolds, a unit of Reynolds American, toward a new marketing strategy. The goal is to refocus on the biggest, most popular -- and most profitable -- brands, which include Kool as well as Camel.

"What we're about is giving adult smokers a choice," says one executive, "with products we believe are more appealing than existing products." The introduction of Camel No. 9 is part of plans to "focus on products that are 'wow,' " she added, "that add fun and excitement to the category."

Fun and excitement? Believe me, there's nothing fun and exciting about cancer. Now if I could only package that truth and market it to the world. I suspect I'd be a rich woman -- and I don't mean financially.

If you are trying to ward off cancer by making a change in your smoking habits, cutting back isn't enough. Cutting out cigarettes altogether is the only way to really protect your health.

Think about this tidbit I found in the March 2007 issue of Woman's Day Magazine.

A 20-year-study of more than 50,000 people in Norway recently revealed that patients who smoked fewer cigarettes -- even those who cut back by half -- were just as likely as heavy smokers to suffer from early death due to cardiovascular disease, cancer, and other tobacco-related problems.

It seems screening for lung cancer doesn't save lives and it doesn't prevent advanced disease. But it does lead to potentially unnecessary and harmful treatment.

This isn't the final word on the use of CT scans to screen smokers and former smokers for the disease. But right now, the hope some experts had for the special X-rays to detect tiny lung abnormalities has been diminished by a large study that is still in the works. And until conclusive evidence says the screening is useful, the American Cancer Society will not endorse the test.

While CT screening did increase diagnosis and treatment -- those screened were three times more likely to be diagnosed with lung cancer and 10 times more likely to have lung surgery than predicted -- study co-author Dr. Peter Bach of Memorial Sloan-Kettering Cancer Center in New York says, "We don't see a trace of evidence that a single life was saved, that a single case of advanced cancer was avoided."

And because CT scanning led to more biopsies and surgeries, patients were put at risk for complications such as lung puncture, bleeding, and infection, according to Bach, whose work is published in the Journal of the American Medical Association.

"Getting screened for lung cancer with CT scanning is not only unproven, it's potentially a risky endeavor," he said.

Until an effective screening tool emerges -- possibly still years away -- experts say there is one surefire way to protect yourself from lung cancer. Stop smoking.

The U.S. government's Institute of Medicine reported that asbestos, which is accepted as a cause of a number of respiratory ailments including lung cancer, may also be a source for laryngeal cancer. The larynx produces the sound of your voice. Each year in the United States, more than 10,000 people learn they have larynx cancer. Men are four times more likely than women to get cancer of the larynx. Occupational related issues are certainly a factor with mechanics, construction, and other jobs that handle asbestos.

A series of studies have found that certain cancers of the throat and lungs are similar, so the U.S. Senate asked the institute to investigate a potential link between asbestos and other upper-body cancers. Asbestos is also linked to mesothelioma which is a rare cancer that attacks the lining of the chest.

Smokers and smokers that drink alcohol are even more at risk to develop cancer of the larynx. Symptoms of larynx cancer are hoarseness or other voice changes,lump in the neck, a sore throat or feeling that something is stuck in your throat, a cough that does not go away, breathing problems, bad breath, earaches, and weight loss.

The American Journal of Preventive Medicine issued a report that stated American cigarette warning labels are the smallest and have the least detail printed, making them the least effective.

Other countries such as Canada, Australia, and Britain have warnings that are much larger and include more health information appearing on both sides of the packages. Some countries even have very graphic warning labels printed on their cigarettes.

A study was conducted to see if these larger, more informed labels could make a difference. The study included 15,000 adult smokers in the U.S., U.K, Canada, and Australia to test the effectiveness of the warning labels used in those four countries between 2002 - 2005.

The research did suggest that U.S. smokers might benefit from large graphic warnings on the packages. The U.S. smokers were least likely to notice their American labeling. The researchers also concluded that the U.S. warnings are poor compared to those in other countries.

It is suggested that the U.S. labels need a makeover and putting quit-smoking resources on cigarette packages might also help.

Secondhand smoke rears its ugly head once again -- this time in the form of study results revealing high levels of secondhand smoke in the workplace can double the risk of lung cancer for non-smokers.

Researchers at the University of Illinois at Chicago looked at results from 22 studies conducted in the United States, Canada, Europe, India, Japan, and China. What they found -- and published in the American Journal of Public Health -- is a lung cancer risk 50 percent higher than normal for non-smokers exposed to smoke on the job for more than 30 years. They also found risk increases with level of exposure.

"We believe that our study provides the strongest evidence to date that smoking in the workplace does present a substantial risk to workers -- and particularly to workers who are working in highly exposed areas such as bar workers or restaurant workers," lead researcher Leslie Stayner said.

Previous evidence for increased lung cancer risk caused by secondhand smoke comes from studies of non-smokers married to smokers.

Secondhand smoke -- also known as passive smoke and environmental tobacco smoke -- is smoke from a cigarette, pipe, or cigar as well as smoke exhaled from the lungs of smokers and inhaled by non-smokers. It can cause cancer, respiratory problems, and asthma in non-smokers and is leading to increased efforts by communities to ban or limit smoking in the workplace.

This week in France, bans begin in offices, stores, schools, and hospitals. Come January 2008, cafes and restaurants must also comply with bans. For now, smoking in these areas is permitted in hermetically sealed rooms without any services.

This past summer, a man in the business of helping smokers quit, was diagnosed with inoperable lung cancer. Just months later, anti-smoking guru Allen Carr lost his battle with cancer. On November 29th, Carr died at his home in Malaga, Spain.

A heavy smoker for 33 years before quitting 23 years ago, Carr claimed to have found an easy way to quit smoking. From that discovery, he founded The Easy Way to Stop Smoking Program, which would eventually grow into 70 clinics in 30 countries. In addition, his company publishes how-to quit smoking books, CDs, tapes and DVDs.

Using cognitive therapy, Carr told smokers interested in quitting that they could do it without willpower, without suffering withdrawal and without gaining weight. The celebrity endorsements for his program include Sir Anthony Hopkins, Sean Bean, Marie Helvin, Johnny Cash, George Harrison, Lisa Stansfield, Sir Richard Branson, Britney Spears, Susannah York, Bruce Oldfield, Stefano Gabbana and Julie Christie.

Carr is credited with helping over 25 million people to quit smoking.

An Easy Way to Stop Smoking Program clinic spokesperson was quoted as saying, "Allen spent many years in smoke-filled rooms after he quit, while treating smokers for addiction. He is certain that had he not quit, he would have died 20 years ago." Near the time of his death, Carr wrote a letter to Tony Blair urging his government and NHS to accept the easy method program. Carr was 72.

Those who just can't quit smoking may have a teeny, tiny bit of added protection from a possible onset of lung cancer -- if they are willing to get out there and sweat.

In a study of older women, researchers found that physically active smokers have a 35 percent lower risk of developing lung cancer than their sedentary counterparts.

This doesn't mean that women who exercise have a free pass to smoke, but the study does reveal the lowest risk of lung cancer among study participants was found in those who had moderate workouts more than four times per week, or vigorous workouts two or more times per week.

It is unclear why physical activity might have a preventive effect on lung cancer. Perhaps the improved pulmonary function resulting from exercise reduces the concentration of carcinogenic particles that deposit in the lungs. Or maybe becoming more physically active increases smokers' awareness of the damage they have caused their lungs, motivating them to smoke less or quit.

One thing is clear, however. The single most important step a smoker can take to prevent lung cancer is quitting the nasty habit -- because those who stop smoking are 10 times less likely to develop lung cancer than those who smoke.

Dr. Norman Edelman, chief medical officer for the American Lung Association does not want smokers to gain a false sense of security from this study.

"We don't want people to get the wrong message," Edelman said. "A regular smoker has a risk of lung cancer 10 times that of a nonsmoker, and 35 percent reduction in that risk is trivial."

Edelman also states that the study does not address the effect of exercise on other smoking-related health problems, such as emphysema and heart disease. And because the active women in the study were less likely to be overweight, it is unclear if the lower lung cancer rate is a result of their exercising or their weight.

In a Phase III trial involving 878 lung cancer patients, the drug bevacizumab, known as Avastin, increased the overall survival rate to 35 percent when combined with the chemotherapy drugs paclitaxel and carboplatin. Patients who were given paclitaxel and carboplatin without Avastin had a 15 percent chance of responding to treatment.

Two months ago, the Food and Drug Administration approved Avastin as a first-line treatment for patients with inoperable, locally advanced, recurrent or metastatic non-squamous, non-small cell lung cancer. Avastin works by stopping the formation of blood vessels that feed oxygen and nutrients needed for tumor growth. Because the drug is a targeted therapy, in that it leaves healthy tissue alone while going after cancer cells, some of the traditional side-effects from conventional chemotherapy, such as hair loss, nausea, or vomiting, are avoided.

According to Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Chief of Hematology/Oncology's Dr. Joan Schiller, "Twenty years ago, we thought no treatment could help patients with advanced lung cancer. Ten years ago, we found that chemotherapy could improve survival of these patients. Now, we are finding out that this very unique drug called Avastin can also help improve survival even more. Avastin is the first of this very exciting family of drugs to be approved for lung cancer, and there are several other drugs of this type under development which may prove to work even better."

Cervical cancer was once the most common cancer in women. But between 1955 and 1992, the number of cervical cancer deaths dropped by 74 percent -- thanks to increased use of the Pap test, a screening tool that can find changes in the cervix before cancer develops and can also detect cancer in its most curable stage. The Pap test is still widely used. And the cervical cancer death rate continues to drop four percent every year.

In 2006, about 9,700 new cases of invasive cervical cancer will be diagnosed in the United States. About 3,700 women will die from the disease. Non-invasive cervical cancer is believed to be four times more common than the invasive form of the disease. Nearly all of these cases can be cured.

Cervical cancer typically occurs in women between the ages of 35 and 55 and rarely in women under the age of 20. It affects mostly Hispanic women, and African-American women develop the disease 50 percent more often than non-Hispanic white women. Women most as risk for cervical cancer are smokers, those with HIV or chlamydia infections, those with diets low in fruit and vegetable consumption, those who between 1940 and 1971 took the hormonal drug DES, and those who have taken oral contraceptives for extended periods of time. Women who have had multiple pregnancies, have a family history of the disease, and have a low socio-economic status are also at risk. Those most at risk, however, are women with human papilloma virus.

Human papilloma virus (HPV) is the most common risk factor for cervical cancer, and some experts believe a woman must have HPV to contract cervical cancer. There are 100 different types of HPV, 13 of which are likely to cause cervical cancer through sexual contact. There are usually no symptoms of HPV, but possible signs of cervical cancer can include vaginal bleeding, unusual discharge, pelvic pain, and pain during sexual intercourse.

There are two ways to stop cervical cancer. First, women can protect themselves against HPV. Protection comes in the form of delaying sexual activity, limiting the amount of sexual partners and their partners, using condoms (thought to be 70 percent effective) and receiving the cervical cancer vaccine, recommended for use in females ages 11-26. The vaccine is most effective for women who have never been sexually active. Second, women can receive regular Pap tests in order to catch pre-cancers. Pap tests are recommended for women three years after their first sexual encounter and before the age of 21 -- and then every year after that.

An abnormal Pap test typically prompts a colposcopy -- a technique that uses a scope to examine the cervix. Diagnosis usually stems from a combination of other scoping methods, pelvic exams, imaging tests, and biopsies used to confirm the presence of cancer and to stage the disease. Stages range from 0-4.

For non-invasive cervical cancer, surgery -- ranging from removal of the cancerous tissue to hysterectomy -- may be the only treatment necessary. For invasive forms of the cancer, surgery is often followed by radiation and chemotherapy. Women interested in preserving their fertility should discuss options with their physicians.

The state of cervical cancer has come a long way over the years. And this year, two critical developments emerged. In June 2006, the FDA approved the first drug for late-stage cervical cancer. The drug, Hycamtin, is recommended for use in combination with chemotherapy. Also is June, the cervical cancer vaccine, Gardasil, was released. Both developments are monumental -- and both will undoubtedly help decrease the already-dropping cervical cancer death rate.

For more information about cervical cancer, visit the following sites:

American Cancer Society
Mayo Clinic
Medline Plus
National Women's Health Information Center

My mom's best friend died from pancreatic cancer just three months after her diagnosis with the disease. One of my co-workers lost her mother to the same disease just weeks after diagnosis. Another co-worker's husband lost his battle with pancreatic cancer after a 15-month all-out fight. And a family friend has somehow been surviving this deadly disease for years now. He's the exception, defying the odds rarely in favor of long-term survival.

About 33,730 people will be diagnosed with pancreatic cancer in 2006. Many of them -- 32,300 -- will die from the disease that is rarely caught early. Pancreatic cancer is the fifth leading cause of cancer death in the United States.

Is it a sign of the times? A harbinger of things to come? A chilling move to bar patients from receiving medical care who fall into categories that make them less than ideal patients?

According to UK's Daily Mail reporting, last year it was obese patients in east Suffolk who were refused medical care involving surgery. Now, if you are a patient treated through the Norfolk Primary Care Trust or Newcastle-Under-Lyme PCT in north Staffordshire, in need of life-changing surgery and smoke, you will be denied care unless you quit smoking.

It appears to be a matter of saving money. Public health trusts are stating that smokers suffer more complications after surgery and require more care which translates into higher health care treatment costs in financial dollars.

It would be a good idea for people who are overweight to maintain a healthy weight. Being overweight can lead to a diminished physical quality of life and disease. It would be a good idea for a smoker to quit smoking. Smoking is bad for your health, no doubt. Each of us should feel a sense of personal responsibility to live as healthy as possible to avoid disease, and to a certain extent be held accountable for the choices we make. But to be denied medical care? Today it is hip and knee replacements. Tomorrow?

This new health care policy seems a slippery slope. It makes me feel uneasy -- not reflecting our most humane and compassionate nature. It raises more than a few questions. One day, will there be additional lifestyle choices added to the criteria of who is denied care? Cancer treatments are very expensive. Could we see a day, in order to keep costs down, that some cancer patients would be denied care based on lifestyle choices? More than one expert has suggested a significant percentage of cancer development is based on lifestyles. I am just wondering where this type of policy might eventually lead.

How does the policy in cutting health care costs based on a patient's weight or lifestyle habits make you feel? Would you be in agreement to deny care to someone who practices a lifestyle habit deemed unhealthy?

On the anniversary of ABC News anchor Peter Jennings lung cancer death, Diane Sawyer spoke with medical editor Dr. Timothy Johnson about the impact Jennings death had for smokers. He indicated that while they do not have exact numbers, ABC was overwhelmed with telephone calls and emails from smokers asking for help or saying they were going to quit smoking as a result of the loss of Jennings.

There are 48 million smokers in the US, and 40 percent have tried to quit smoking. According to Dr. Johnson, only 20 percent of smokers who try to quit make use of aids available to help them -- patches, gum, antidepressants -- and only 5 percent of smokers are able to quit long term.

When Sawyer asked what message Dr. Johnson felt Jennings would want to convey to smokers, he said that Jennings would say, "keep trying, no matter how many times you try and fail to quit, keep trying -- each time you do is one more chance to become successful at quitting for good."

Dr. Johnson said Jennings, who admitted he was a heavy smoker for years before quitting, was a fighter. Dr. Johnson said Jennings would tell everyone who smokes to keep fighting to quit. ABC News has made the video of the interview, One Year Later: The Impact of Peter Jennings' Death, available online.

Watercress is one of the richest sources of dietary phenylethyl isothiocyanate (PEITC). PEITC has been shown to inhibit phase 1 enzyme activation. Effectively it stops potential carcinogens becoming carcinogenic. Watercress is a member of the cruciferous vegetable family that includes broccoli, kale and mustard greens. Watercress leaves are tiny and glossy green with a peppery taste and pack a powerful punch of cancer fighting agents especially cancers related to smokers like lung and esophageal. This simple salad is packed full of nutrients and vitamins and is easy to prepare. As always remember to buy organic products when you can.

Vicki's Watercress and Orange Salad
1 Bag or bunch of watercress rinsed well and patted dry
1 bunch of fresh asparagus cut in 1" pieces
2 cups orange wedges peeled
1/2 cup craisins (dried cranberries)
1/4 cup sliced almonds

Vicki's Simple Citrus Dressing:
1/4 Cup orange juice
1 tablespoon lime juice
2 tablespoons extra virgin olive oil
2 tablespoons honey

In a small bowl combine all the dressing ingredients and chill for 5 minutes. Blanch asparagus in boiling water for 3-5 minutes keeping it crisp but a little tender. Drain and rinse in cold water. In a large bowl mix the watercress orange wedges, craisins, and asparagus and toss with the dressing. Sprinkle the sliced almonds on top and serve immediately.

The Chronic Survival Tour: Shedding Light on Lung Cancer features the world-renowned fantasy art of Tom Cross, his battle with lung cancer, education about lung cancer and as a benefit to raise money for advocacy groups such as the Lung Cancer Online Foundation. The nationwide traveling exhibit of original art, prints and books featuring fairies, wizards, elves and mermaids created by Cross, is a way to share his lung cancer survivorship and to shed light on the misinformation about lung cancer that dominates common perception for one of the deadliest cancers.

Diagnosed in 2003, Cross is not a smoker but feels the stigma associated with being a lung cancer patient when people hold the opinion that lung cancer is a self-inflicted disease -- a karma of bad habit. Cross hopes his art and his touring exhibit can change the minds of the community.

Cross states, "It is my hope that through my art, participation in lung cancer awareness organizations and activities, and events such as this, that some small difference may be made to bring hope and someday a cure to this and all cancer afflictions." Cross is an artist, author, ecologist and designer. His work is exquisite. You can purchase his art online at The Wondrous Worlds of Tom Cross.